BVI’s next-generation cataract and vitreoretinal procedure platform has been developed with features that are intended at ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...

As cataract surgery evolves toward a precision refractive paradigm, the accuracy of postoperative refractive prediction for ...

Performing cataract surgery on a patient with a history of radial keratotomy is one of the most challenging scenarios in ...

There are some topics that are so central to the experiences of both doctors and patients that they deserve an annual ...

Uncorrected acuity at 36 months showed continuous range: monocular 20/20 distance and intermediate, 20/27 near; binocular ...

On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...

RxSight continues to expand access to the Light Adjustable Lens through its growing network of trained surgeons and certified practices across the United States and select international markets. The ...

Johnson & Johnson (NYSE:JNJ) presented new clinical data on its recently FDA-approved TECNIS PureSee intraocular lens at the ...

RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, ...

BVI Medical announced today that it received CE mark for its Virtuoso next-generation phaco-vitrectomy surgical platform.

Johnson & Johnson MedTech reported 4.6% growth in Q1, driven by a strong pipeline of cardiovascular and surgical innovations.